| scholarly article | Q13442814 |
| P2093 | author name string | Yadong Wang | |
| Lei Kang | |||
| Caiyan Zhao | |||
| Chuan Shen | |||
| Wenpeng Liu | |||
| Juqiang Han | |||
| Zhifeng Yan | |||
| Yanhong Tai | |||
| P2860 | cites work | Global cancer statistics | Q22241238 |
| Hallmarks of Cancer: The Next Generation | Q22252312 | ||
| Understanding the Warburg effect: the metabolic requirements of cell proliferation | Q24604760 | ||
| MicroRNA signatures in human cancers | Q27860962 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| The phosphatidylinositol 3-Kinase AKT pathway in human cancer | Q29547860 | ||
| Hepatocellular carcinoma pathogenesis: from genes to environment | Q29615767 | ||
| Hepatocellular carcinoma | Q29615841 | ||
| Management of hepatocellular carcinoma | Q29616230 | ||
| Insulin and insulin-like growth factor signalling in neoplasia | Q29619495 | ||
| Prognostic value of miR-221-3p, miR-342-3p and miR-491-5p expression in colon cancer | Q33961980 | ||
| Can we unlock the potential of IGF-1R inhibition in cancer therapy? | Q34336988 | ||
| Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking | Q35723690 | ||
| Targeting glucose metabolism for cancer therapy | Q35760864 | ||
| Insulin-like growth factor-I induces cyclooxygenase-2 expression via PI3K, MAPK and PKC signaling pathways in human ovarian cancer cells | Q36016357 | ||
| Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma | Q36560956 | ||
| The insulin-like growth factor 1 receptor in cancer: old focus, new future | Q36877168 | ||
| Long non-coding RNA H19 regulates FOXM1 expression by competitively binding endogenous miR-342-3p in gallbladder cancer | Q37307816 | ||
| Predictive microRNAs for lymph node metastasis in endoscopically resectable submucosal colorectal cancer | Q37362799 | ||
| Review article: the management of hepatocellular carcinoma | Q37635285 | ||
| Activation of the PI3K/AKT pathway correlates with prognosis in stage II colon cancer | Q37711623 | ||
| The insulin and insulin-like growth factor receptor family in neoplasia: an update | Q37984217 | ||
| Postoperative prognosis prediction of pancreatic cancer with seven microRNAs | Q38386732 | ||
| Identification of AKT kinases as unfavorable prognostic factors for hepatocellular carcinoma by a combination of expression profile, interaction network analysis and clinical validation | Q38483244 | ||
| miR-342-3p regulates MYC transcriptional activity via direct repression of E2F1 in human lung cancer. | Q38826529 | ||
| miR-342-3p targets RAP2B to suppress proliferation and invasion of non-small cell lung cancer cells | Q38911621 | ||
| miR-342-3p suppresses proliferation, migration and invasion by targeting FOXM1 in human cervical cancer | Q38971233 | ||
| The insulin-like growth factor-I receptor inhibitor picropodophyllin-induced selective apoptosis of hepatocellular carcinoma cell through a caspase-dependent mitochondrial pathway. | Q39036005 | ||
| PTEN dephosphorylates AKT to prevent the expression of GLUT1 on plasmamembrane and to limit glucose consumption in cancer cells | Q39201094 | ||
| MicroRNAs in gynecological cancers: Small molecules with big implications | Q39333266 | ||
| Apigenin inhibits the GLUT-1 glucose transporter and the phosphoinositide 3-kinase/Akt pathway in human pancreatic cancer cells | Q39924854 | ||
| Characterization of microRNA expression levels and their biological correlates in human cancer cell lines | Q40158414 | ||
| The role of the insulin-like growth factor system in human cancer | Q41035980 | ||
| Prognostic value of insulin- like growth factor-I receptor expression in renal cell carcinoma. | Q43198394 | ||
| Expression of insulin-like growth factor receptor type 1 correlate with lymphatic metastases in human gastric cancer. | Q43725019 | ||
| Modern diagnosis and management of hepatocellular carcinoma. | Q46011780 | ||
| Increased activated Akt expression in renal cell carcinomas and prognosis | Q46386017 | ||
| Akt is frequently activated in HER2/neu-positive breast cancers and associated with poor prognosis among hormone-treated patients | Q46623138 | ||
| miR-342-3p suppresses cell proliferation and migration by targeting AGR2 in non-small cell lung cancer. | Q47437057 | ||
| Phosphorylated AKT expression in tumor-adjacent normal tissue is associated with poor prognosis in patients with hepatocellular carcinoma | Q47552146 | ||
| Alpha-fetoprotein for hepatocellular carcinoma diagnosis: the demise of a brilliant star. | Q47689923 | ||
| Effects of Glut1 gene silencing on proliferation, differentiation, and apoptosis of colorectal cancer cells by targeting the TGF-β/PI3K-AKT-mTOR signaling pathway | Q47835957 | ||
| MicroRNA-320a suppresses in GBM patients and modulates glioma cell functions by targeting IGF-1R. | Q48607854 | ||
| Aberrant SIRT6 expression contributes to melanoma growth: Role of the autophagy paradox and IGF-AKT signaling | Q50035013 | ||
| MicroRNA-342-3p Inhibits the Proliferation, Migration, and Invasion of Osteosarcoma Cells by Targeting Astrocyte-Elevated Gene-1 (AEG-1). | Q50853847 | ||
| miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-κB pathway. | Q50978200 | ||
| Genetics of mouse growth | Q77684683 | ||
| Insulin-like growth factors and neoplasia | Q81055096 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 1643-1653 | |
| P577 | publication date | 2018-03-23 | |
| P1433 | published in | OncoTargets and Therapy | Q7092081 |
| P1476 | title | miR-342-3p suppresses hepatocellular carcinoma proliferation through inhibition of IGF-1R-mediated Warburg effect. | |
| P478 | volume | 11 |
| Q92855414 | Can Epigenetics of Endothelial Dysfunction Represent the Key to Precision Medicine in Type 2 Diabetes Mellitus? |
| Q89868682 | Downregulation of miR-193a-3p is involved in the pathogenesis of hepatocellular carcinoma by targeting CCND1 |
| Q97419057 | Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma |
| Q89558440 | Knockdown of lncRNA SNHG16 suppresses multiple myeloma cell proliferation by sponging miR-342-3p |
| Q64060114 | LncRNA SNHG7 promotes pancreatic cancer proliferation through ID4 by sponging miR-342-3p |
| Q58774468 | Loss of function of miR-342-3p results in MCT1 over-expression and contributes to oncogenic metabolic reprogramming in triple negative breast cancer |
| Q57178939 | Metadherin is an apoptotic modulator in prostate cancer through miR-342-3p regulation |
| Q59794351 | MicroRNA-18a promotes hepatocellular carcinoma proliferation, migration, and invasion by targeting Bcl2L10 |
| Q97645838 | MicroRNAs Modulate Drug Resistance-Related Mechanisms in Hepatocellular Carcinoma |
| Q92051398 | Non-Coding RNAs in IGF-1R Signaling Regulation: The Underlying Pathophysiological Link between Diabetes and Cancer |
| Q64108356 | Overexpression of miR-664 is associated with poor overall survival and accelerates cell proliferation, migration and invasion in hepatocellular carcinoma |
| Q61809316 | SENP1 Interacts with HIF1α to Regulate Glycolysis of Prostatic Carcinoma Cells |
| Q90262467 | Semen miRNAs Contained in Exosomes as Non-Invasive Biomarkers for Prostate Cancer Diagnosis |
| Q60957697 | Up-Regulation of MiR-1915 Inhibits Proliferation, Invasion, and Migration of -Infected Gastric Cancer Cells via Targeting RAGE |
| Q92208491 | miR‑342 inhibits glioma cell proliferation by targeting GPRC5A |
| Q64101423 | microRNA-944 inhibits the malignancy of hepatocellular carcinoma by directly targeting IGF-1R and deactivating the PI3K/Akt signaling pathway |
Search more.